drugset
drugset / Trial / NCT05518422

Role of Endothelin-1 Modulating Insulin-stimulated Blood Flow and Sympathetic Nervous System Activity in Obesity

NCT05518422 ↗

Phase 0 Withdrawn University of Missouri-Columbia
NaSingle-groupOpen-labelBasic science

Summary

The aim of this project is to determine role for ET-1 in individuals with obesity.

Timeline

Start
2024-02
Primary completion
2024-02
Completion
2024-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Bosentan Other / unclassified — Oral

Indications

dysautonomia obesity disorder